1 / 2

Precision Diagnostics Market Size & Share Analysis

Precision Diagnostics Market Size & Share Analysis

Manisha109
Download Presentation

Precision Diagnostics Market Size & Share Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Precision Diagnostics Market Analysis 2024-2032 Market Size and Growth The global precision diagnostics market is projected to grow from $85.34 billion in 2024 to $229.27 billion by 2032, at a CAGR of 13.1%. North America leads with 37.36% market share as of 2023. Key Market Drivers  Rising cancer prevalence: The National Cancer Institute projects new cancer cases will reach 29.5 million and cancer-related deaths 16.4 million annually by 2040  Increased demand for personalized medicine and early disease detection  COVID-19 impact: Accelerated adoption of precision diagnostics, with the U.S. accounting for 96.2% of North American cases in May 2021 Market Segments By Type  Genetic Tests (largest segment)  Esoteric Tests  Others (direct-to-consumer tests) By Application  Oncology (fastest growing)  Cardiovascular  Immunology  Neurology By End User  Clinical Laboratories (dominant segment)  Hospitals  Homecare Recent Developments  January 2024: Siemens Healthineers partnered with Indian Institute of Science to advance precision medicine through AI and machine learning  January 2023: Apollo Cancer Centre launched India's first Precision Oncology Centre with AI technology  May 2023: Bayer introduced a dedicated Precision Health business division Regional Analysis  North America: Market valued at $28.34 billion in 2023, driven by established healthcare infrastructure

  2. Europe: Growth fueled by technological advancements and COVID-19 impact  Asia Pacific: Fastest growing region, driven by rising chronic disease prevalence  Latin America and Middle East & Africa: Slower growth due to lower awareness and limited reimbursement policies Key Market Players  Quest Diagnostics (U.S.)  QIAGEN (Germany)  Swiss Precision Diagnostics (Switzerland)  Koninklijke Philips N.V (Netherlands)  Lantheus Medical Imaging (U.S.)  Bluebird Bio (U.S.) Market Challenges  High capital investment requirements for R&D  Data privacy and security concerns  Strict regulatory requirements  Need for skilled personnel to manage data and algorithms Footnotes Fortune Business Insights - Precision Diagnostics Market Size, Share | Growth Report [2032] https://www.fortunebusinessinsights.com/industry-reports/precision-diagnostics-market-100357

More Related